Zynerba Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Highlights
May 09, 2017 11:31 am UTC| Business
DEVON, Pa., May 09, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid...
Zynerba Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Highlights
May 09, 2017 11:31 am UTC| Business
DEVON, Pa., May 09, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid...
FinalCode Announces Global Launch of FinalCode Express Edition
May 09, 2017 11:31 am UTC| Business
SAN JOSE, Calif., May 09, 2017 -- FinalCode, Inc., a leading provider of information security software, today announced the immediate global availability of FinalCode® Express Edition, a new product version that...
FinalCode Announces Global Launch of FinalCode Express Edition
May 09, 2017 11:31 am UTC| Business
SAN JOSE, Calif., May 09, 2017 -- FinalCode, Inc., a leading provider of information security software, today announced the immediate global availability of FinalCode® Express Edition, a new product version that...
FinalCode Launches Client for Mac Worldwide
May 09, 2017 11:31 am UTC| Business
SAN JOSE, Calif., May 09, 2017 -- FinalCode, Inc., a leading provider of information security software, today announced the immediate global availability of FinalCode® Client for Mac. Now FinalCode, a persistent,...
FinalCode Launches Client for Mac Worldwide
May 09, 2017 11:31 am UTC| Business
SAN JOSE, Calif., May 09, 2017 -- FinalCode, Inc., a leading provider of information security software, today announced the immediate global availability of FinalCode® Client for Mac. Now FinalCode, a persistent,...
May 09, 2017 11:30 am UTC| Business
Once Monthly Dosing Would Represent a 50% Reduction in Patient Infusions Unique Chemical Modifications to pegunigalsidase alfa Result in a Significantly Longer Half-life Allowing for the Potential of Effective Drug...